Cargando…
Ultra-Long-Term Therapy of Benign Essential Blepharospasm with Botulinumtoxin A—30 Years of Experience in a Tertiary Care Center
Aim of this study was to investigate the long-term results of botulinum toxin A (BoNT-A) injections for the treatment of benign essential blepharospasm (BEB) and to report our experience with (ultra-)long-term treatment with onabotulinumtoxin-A. We conducted a retrospective cross-sectional analysis...
Autores principales: | Wabbels, Bettina, Fimmers, Rolf, Roggenkämper, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8875585/ https://www.ncbi.nlm.nih.gov/pubmed/35202148 http://dx.doi.org/10.3390/toxins14020120 |
Ejemplares similares
-
Difficulties with differentiating botulinum toxin treatment effects in essential blepharospasm
por: Wabbels, Bettina, et al.
Publicado: (2011) -
Botulinum Toxin Therapy in Congenital Blepharospasm
por: Wabbels, Bettina
Publicado: (2014) -
Depression in blepharospasm: a question of facial feedback?
por: Bedarf, Janis Rebecca, et al.
Publicado: (2017) -
Animal Models for Investigating Benign Essential Blepharospasm
por: Evinger, Craig
Publicado: (2013) -
Frequency of Hemorrhagic Side Effects of Botulinum Neurotoxin Treatment in Patients with Blepharospasm and Hemifacial Spasm on Antithrombotic Medication
por: Wenninger, Fiona Carolin, et al.
Publicado: (2022)